Real-world safety profile of eculizumab in patients with paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, or generalized myasthenia gravis: an integrated analysis of post-marketing surveillance in Japan Jun-ichi NishimuraTatsuya KawaguchiShoichi Maruyama Original Article 29 July 2023 Pages: 419 - 431
Lenalidomide treatment of Japanese patients with myelodysplastic syndromes with 5q deletion: a post-marketing surveillance study Shuji UnoYoko MotegiYasuo Aoki Original Article Open access 26 July 2023 Pages: 432 - 442
A retrospective analysis of clinical features and treatment outcome in 21 patients with immunoglobulin M-related light-chain amyloidosis in Japan: a study from the Amyloidosis Research Committee Shin-ichi FuchidaMizuki OguraChihiro Shimazaki Original Article 29 July 2023 Pages: 443 - 449
Substitution of calcineurin inhibitors with corticosteroids after allogeneic hematopoietic cell transplantation Shimpei MatsumiShun-ichi KimuraYoshinobu Kanda Original Article 22 July 2023 Pages: 450 - 461
Antibody response after third dose of COVID-19 mRNA vaccination in allogeneic hematopoietic stem cell transplant recipients is comparable to that in healthy counterparts Erina TakagiSeitaro TerakuraHitoshi Kiyoi Original Article 10 August 2023 Pages: 462 - 471
A case of cold agglutinin syndrome associated with chronic lymphocytic leukaemia harbouring mutations in CARD11 and KMT2D Masahiko FukatsuYoichi HamazakiTakayuki Ikezoe Case Report 03 May 2023 Pages: 472 - 476
New onset of hypomegakaryocytic thrombocytopenia with the potential for progression to aplastic anemia after BNT162b2 mRNA COVID-19 vaccination Mirei KobayashiAkio MoriTakeshi Kondo Case Report Open access 23 May 2023 Pages: 477 - 482
Venetoclax with CAG regimen for early T-cell precursor acute lymphoblastic leukemia: a case report and literature review Yihan ZhaoShiqing JiangLin Zhao Case Report 03 June 2023 Pages: 483 - 488
Mutated ZRSR2 and CUL3 accelerate clonal evolution and confer venetoclax resistance via RAS signaling pathway in blastic plasmacytoid dendritic cell neoplasm Koichiro FukuchiDaisuke KoyamaTakayuki Ikezoe Case Report 08 April 2023 Pages: 489 - 493
Clinical and genetic features of Japanese cases of MDS associated with VEXAS syndrome Hiroyoshi KunimotoAyaka MiuraHideaki Nakajima Case Report 17 April 2023 Pages: 494 - 502
Newly diagnosed extranodal NK/T-cell lymphoma, nasal type, at the injected left arm after BNT162b2 mRNA COVID-19 vaccination Takuto TachitaTakenori TakahataHirotake Sakuraba Case Report 24 April 2023 Pages: 503 - 507
Transcriptome sequencing identifies novel EVX fusions involved in transcriptional activation of HOX family genes in pediatric immature T-cell acute lymphoblastic leukemia: two cases reports and a literature review Xiao ZhangBowen CuiShaoyan Hu Case Report 27 May 2023 Pages: 508 - 513
Acute monocytic leukemia with KMT2A::LASP1 developed 9 months after diagnosis of acute megakaryoblastic leukemia in a 2-year-old boy Takashi FujitaHiroko FukushimaHidetoshi Takada Case Report 14 June 2023 Pages: 514 - 518
Successful treatment of DOCK8 deficiency by allogeneic hematopoietic cell transplantation from alternative donors Asuka KonoManabu WakamatsuHirokazu Kanegane Case Report 03 May 2023 Pages: 519 - 525
Measurable residual disease in Japanese patients with relapsed or refractory chronic lymphocytic leukemia treated with venetoclax Koji IzutsuKazuhito YamamotoDai Maruyama Letter to the Editor Open access 15 August 2023 Pages: 526 - 528